{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:37:41Z","timestamp":1770521861320,"version":"3.49.0"},"posted":{"date-parts":[[2023,4,12]]},"group-title":"Neuroscience","reference-count":60,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,4,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Cognitive dysfunction is a salient feature of Parkinson\u2019s disease (PD) and Dementia with Lewy bodies (DLB). The onset of dementia reflects the spread of Lewy pathology throughout forebrain structures. The mere presence of Lewy pathology, however, provides limited indication of cognitive status. Thus, it remains unclear whether Lewy pathology is the de facto substrate driving cognitive dysfunction in PD and DLB. Through application of \u03b1-synuclein fibrils\n                  <jats:italic>in vivo<\/jats:italic>\n                  , we sought to examine the influence of pathologic inclusions on cognition. Following stereotactic injection of \u03b1-synuclein fibrils within the mouse forebrain, we measured the burden of \u03b1-synuclein pathology at 1-, 3-, and 6-months post-injection within subregions of the hippocampus and cortex. Under this paradigm, the hippocampal CA2\/3 subfield was especially susceptible to \u03b1- synuclein pathology. Strikingly, we observed a drastic reduction of pathology in the CA2\/3 subfield across time-points, consistent with the consolidation of \u03b1-synuclein pathology into dense somatic inclusions followed by neurodegeneration. Silver-positive degenerating neurites were observed prior to neuronal loss, suggesting that this might be an early feature of fibril-induced neurotoxicity and a precursor to neurodegeneration. Critically, mice injected with \u03b1-synuclein fibrils developed progressive deficits in spatial learning and memory. These findings support that the formation of \u03b1-synuclein inclusions in the mouse forebrain precipitate neurodegenerative changes that recapitulate features of Lewy-related cognitive dysfunction.\n                <\/jats:p>\n                <jats:sec id=\"s55\">\n                  <jats:title>Highlights<\/jats:title>\n                  <jats:list list-type=\"bullet\">\n                    <jats:list-item>\n                      <jats:p>Mice injected with \u03b1-synuclein fibrils develop hippocampal and cortical \u03b1- synuclein pathology with a dynamic regional burden at 1-, 3-, and 6-months post-injection.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Silver-positive neuronal processes are an early and enduring degenerative feature of the fibril model, while extensive neurodegeneration of the hippocampal CA2\/3 subfield is detected at 6-months post-injection.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Mice exhibit progressive hippocampal-dependent spatial learning and memory deficits.<\/jats:p>\n                    <\/jats:list-item>\n                    <jats:list-item>\n                      <jats:p>Forebrain injection of \u03b1-synuclein fibrils may be used to model aspects of Lewy-related cognitive dysfunction.<\/jats:p>\n                    <\/jats:list-item>\n                  <\/jats:list>\n                <\/jats:sec>","DOI":"10.1101\/2023.04.12.536572","type":"posted-content","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T20:35:11Z","timestamp":1681331711000},"source":"Crossref","is-referenced-by-count":3,"title":["Hippocampal subfield vulnerability to \u03b1-synuclein pathology precedes neurodegeneration and cognitive dysfunction"],"prefix":"10.64898","author":[{"given":"Dylan J.","family":"Dues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An Phu Tran","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5679","authenticated-orcid":false,"given":"Darren J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2023041701551363000_2023.04.12.536572v1.1","doi-asserted-by":"crossref","unstructured":"Goedert M , Spillantini MG , Tredici KD , Braak H . 100 years of Lewy pathology. Nat Rev Neurol. 2013;9:13.","DOI":"10.1038\/nrneurol.2012.242"},{"key":"2023041701551363000_2023.04.12.536572v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"2023041701551363000_2023.04.12.536572v1.3","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20834"},{"key":"2023041701551363000_2023.04.12.536572v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2010.04.003"},{"key":"2023041701551363000_2023.04.12.536572v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-4580(02)00065-9"},{"key":"2023041701551363000_2023.04.12.536572v1.6","doi-asserted-by":"crossref","unstructured":"Henderson MX , Henrich MT , Geibl FF , Oertel WH , Brundin P , Surmeier DJ . The roles of connectivity and neuronal phenotype in determining the pattern of \u03b1-synuclein pathology in Parkinson\u2019s disease. Neurobiol Dis. 2022;105687.","DOI":"10.1016\/j.nbd.2022.105687"},{"key":"2023041701551363000_2023.04.12.536572v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu193"},{"key":"2023041701551363000_2023.04.12.536572v1.8","doi-asserted-by":"crossref","unstructured":"Liu AKL , Chau TW , Lim EJ , Ahmed I , Chang RC-C , Kalaitzakis ME , et al. Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson\u2019s disease with cognitive decline. Acta Neuropathologica Commun. 2019;7:61.","DOI":"10.1186\/s40478-019-0717-3"},{"key":"2023041701551363000_2023.04.12.536572v1.9","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3047-16.2016"},{"key":"2023041701551363000_2023.04.12.536572v1.10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.6.1570"},{"key":"2023041701551363000_2023.04.12.536572v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/s004010100390"},{"key":"2023041701551363000_2023.04.12.536572v1.12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson\u2019s disease: The inevitability of dementia at 20 years","volume":"23","year":"2008","journal-title":"Movement Disord"},{"key":"2023041701551363000_2023.04.12.536572v1.13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh067"},{"key":"2023041701551363000_2023.04.12.536572v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm111"},{"key":"2023041701551363000_2023.04.12.536572v1.15","unstructured":"Papailiou KO , Schmuck F , Zhang B , Kehm V , Gathagan R , Leight SN , et al. Alpha-Synuclein, Methods and Protocols. Methods Mol Biology Clifton N J. 2019;1948:45\u201357."},{"key":"2023041701551363000_2023.04.12.536572v1.16","doi-asserted-by":"crossref","unstructured":"Patterson JR , Polinski NK , Duffy MF , Kemp CJ , Luk KC , Volpicelli-Daley LA , et al. Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo. J Vis Exp Jove. 2019;","DOI":"10.3791\/59758-v"},{"key":"2023041701551363000_2023.04.12.536572v1.17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20112457"},{"key":"2023041701551363000_2023.04.12.536572v1.18","doi-asserted-by":"crossref","unstructured":"Duffy MF , Collier TJ , Patterson JR , Kemp CJ , Fischer DL , Stoll AC , et al. Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson\u2019s Disease. Front Neurosci-switz. 2018;12:621.","DOI":"10.3389\/fnins.2018.00621"},{"key":"2023041701551363000_2023.04.12.536572v1.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1829-8"},{"key":"2023041701551363000_2023.04.12.536572v1.20","doi-asserted-by":"crossref","unstructured":"Wang X , Becker K , Levine N , Zhang M , Lieberman AP , Moore DJ , et al. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathologica Commun. 2019;7:41.","DOI":"10.1186\/s40478-019-0696-4"},{"key":"2023041701551363000_2023.04.12.536572v1.21","doi-asserted-by":"crossref","unstructured":"Br\u00fcck A , Kurki T , Kaasinen V , Vahlberg T , Rinne JO . Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson\u2019s disease is related to cognitive impairment. J Neurology Neurosurg Psychiatry. 2004;75:1467.","DOI":"10.1136\/jnnp.2003.031237"},{"key":"2023041701551363000_2023.04.12.536572v1.22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","article-title":"Hippocampal volume and white matter disease in the prediction of dementia in Parkinson\u2019s disease","volume":"20","year":"2014","journal-title":"Parkinsonism Relat D"},{"key":"2023041701551363000_2023.04.12.536572v1.23","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10444"},{"key":"2023041701551363000_2023.04.12.536572v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/ncb748"},{"key":"2023041701551363000_2023.04.12.536572v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.06.003"},{"key":"2023041701551363000_2023.04.12.536572v1.26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1227157"},{"key":"2023041701551363000_2023.04.12.536572v1.27","doi-asserted-by":"crossref","unstructured":"Patterson JR , Duffy MF , Kemp CJ , Howe JW , Collier TJ , Stoll AC , et al. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal \u03b1-synuclein preformed fibrils. Neurobiol Dis. 2019;104525.","DOI":"10.1016\/j.nbd.2019.104525"},{"key":"2023041701551363000_2023.04.12.536572v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/hipo.10037"},{"key":"2023041701551363000_2023.04.12.536572v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.08.033"},{"key":"2023041701551363000_2023.04.12.536572v1.30","doi-asserted-by":"crossref","unstructured":"Kim S , Nam Y , Jeong Y , Park HH , Lee S , Shin SJ , et al. Topographical Visualization of the Reciprocal Projection between the Medial Septum and the Hippocampus in the 5XFAD Mouse Model of Alzheimer\u2019s Disease. Int J Mol Sci. 2019;20:3992.","DOI":"10.3390\/ijms20163992"},{"key":"2023041701551363000_2023.04.12.536572v1.31","doi-asserted-by":"crossref","unstructured":"Hall H , Jewett M , Landeck N , Nilsson N , Schagerl\u00f6f U , Leanza G , et al. Characterization of Cognitive Deficits in Rats Overexpressing Human Alpha-Synuclein in the Ventral Tegmental Area and Medial Septum Using Recombinant Adeno-Associated Viral Vectors. Plos One. 2013;8:e64844.","DOI":"10.1371\/journal.pone.0064844"},{"key":"2023041701551363000_2023.04.12.536572v1.32","doi-asserted-by":"crossref","unstructured":"Cornblath EJ , Li HL , Changolkar L , Zhang B , Brown HJ , Gathagan RJ , et al. Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor. Sci Adv. 2021;7:eabg6677.","DOI":"10.1126\/sciadv.abg6677"},{"key":"2023041701551363000_2023.04.12.536572v1.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2017.10.017"},{"key":"2023041701551363000_2023.04.12.536572v1.34","doi-asserted-by":"crossref","unstructured":"Kasongo DW , Leo G de, Vicario N, Leanza G, Legname G. Chronic alpha-synuclein accumulation in rat hippocampus induces Lewy Bodies formation and specific cognitive impairments. Eneuro. 2020;ENEURO.0009-20.2020.","DOI":"10.1523\/ENEURO.0009-20.2020"},{"key":"2023041701551363000_2023.04.12.536572v1.35","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607305"},{"key":"2023041701551363000_2023.04.12.536572v1.36","doi-asserted-by":"crossref","unstructured":"Froula JM , Henderson BW , Gonzalez JC , Vaden JH , Mclean JW , Wu Y , et al. \u03b1- Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons. Acta Neuropathologica Commun. 2018;6:35.","DOI":"10.1186\/s40478-018-0537-x"},{"key":"2023041701551363000_2023.04.12.536572v1.37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5607\/en.2010.19.3.115","article-title":"The Role of Axonopathy in Parkinson\u2019s Disease","volume":"19","year":"2010","journal-title":"Exp Neurobiology"},{"key":"2023041701551363000_2023.04.12.536572v1.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0051-5"},{"key":"2023041701551363000_2023.04.12.536572v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2017.05.014"},{"key":"2023041701551363000_2023.04.12.536572v1.40","doi-asserted-by":"crossref","unstructured":"Henderson MX , Sedor S , McGeary I , Cornblath EJ , Peng C , Riddle DM , et al. Glucocerebrosidase Activity Modulates Neuronal Susceptibility to Pathological \u03b1- Synuclein Insult. Neuron. 2019;","DOI":"10.1016\/j.neuron.2019.12.004"},{"key":"2023041701551363000_2023.04.12.536572v1.41","doi-asserted-by":"crossref","unstructured":"Henderson MX , Sengupta M , McGeary I , Zhang B , Olufemi MF , Brown H , et al. LRRK2 inhibition does not impart protection from \u03b1-synuclein pathology and neuron death in non-transgenic mice. Acta Neuropathologica Commun. 2019;7:28.","DOI":"10.1186\/s40478-019-0679-5"},{"key":"2023041701551363000_2023.04.12.536572v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0457-5"},{"key":"2023041701551363000_2023.04.12.536572v1.43","doi-asserted-by":"crossref","unstructured":"Kam T-I , Park H , Chou S-C , Vranken JGV , Mittenb\u00fchler MJ , Kim H , et al. Amelioration of pathologic \u03b1-synuclein-induced Parkinson\u2019s disease by irisin. Proc National Acad Sci. 2022;119:e2204835119.","DOI":"10.1073\/pnas.2204835119"},{"key":"2023041701551363000_2023.04.12.536572v1.44","doi-asserted-by":"crossref","unstructured":"Karampetsou M , Ardah MT , Semitekolou M , Polissidis A , Samiotaki M , Kalomoiri M , et al. Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice. Sci Rep-uk. 2017;7:16533.","DOI":"10.1038\/s41598-017-15813-8"},{"key":"2023041701551363000_2023.04.12.536572v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90010-1"},{"key":"2023041701551363000_2023.04.12.536572v1.46","doi-asserted-by":"crossref","unstructured":"Pitts M . Barnes Maze Procedure for Spatial Learning and Memory in Mice. Bio-protocol. 2018;8.","DOI":"10.21769\/BioProtoc.2744"},{"key":"2023041701551363000_2023.04.12.536572v1.47","doi-asserted-by":"publisher","DOI":"10.1037\/h0077579"},{"key":"2023041701551363000_2023.04.12.536572v1.48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/nan.12698","article-title":"Hippocampal subfield pathologic Burden in Lewy body diseases versus Alzheimer\u2019s disease","volume":"47","year":"2021","journal-title":"Neuropath Appl Neuro"},{"key":"2023041701551363000_2023.04.12.536572v1.49","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296742"},{"key":"2023041701551363000_2023.04.12.536572v1.50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.41.9.1402"},{"key":"2023041701551363000_2023.04.12.536572v1.51","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-005-0004-1"},{"key":"2023041701551363000_2023.04.12.536572v1.52","doi-asserted-by":"crossref","unstructured":"Stoyka LE , Arrant AE , Thrasher DR , Russell DL , Freire J , Mahoney CL , et al. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded \u03b1-synuclein inclusions. Neurobiology of Disease. 2019;104708.","DOI":"10.1016\/j.nbd.2019.104708"},{"key":"2023041701551363000_2023.04.12.536572v1.53","doi-asserted-by":"crossref","unstructured":"Zhang Q , Abdelmotilib H , Larson T , Keomanivong C , Conlon M , Aldridge GM , et al. Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice. Neurosci Lett. 2021;765:136273.","DOI":"10.1016\/j.neulet.2021.136273"},{"key":"2023041701551363000_2023.04.12.536572v1.54","doi-asserted-by":"crossref","unstructured":"Blumenstock S , Sun F , Klaus C , Marinkovi\u0107 P , Sgobio C , Paeger L , et al. Cortical circuit dysfunction in a mouse model of alpha-synucleinopathy in vivo. Brain Commun. 2021;3:fcab273.","DOI":"10.1093\/braincomms\/fcab273"},{"key":"2023041701551363000_2023.04.12.536572v1.55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2016.05.040","article-title":"Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy","volume":"283","year":"2016","journal-title":"Exp Neurol"},{"key":"2023041701551363000_2023.04.12.536572v1.56","first-page":"217","article-title":"Mouse Models of Cognitive Deficits Due to Alpha-Synuclein Pathology","volume":"1","year":"2011","journal-title":"J Park Dis"},{"key":"2023041701551363000_2023.04.12.536572v1.57","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1007-y"},{"key":"2023041701551363000_2023.04.12.536572v1.58","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2014.143"},{"key":"2023041701551363000_2023.04.12.536572v1.59","doi-asserted-by":"crossref","unstructured":"Sargent D , Cunningham LA , Dues DJ , Ma Y , Kordich JJ , Mercado G , et al. Neuronal VPS35 deletion induces spinal cord motor neuron degeneration and early post-natal lethality. Brain Commun. 2021;","DOI":"10.1093\/braincomms\/fcab208"},{"key":"2023041701551363000_2023.04.12.536572v1.60","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1042"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2023.04.12.536572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:32:22Z","timestamp":1768451542000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.04.12.536572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":60,"URL":"https:\/\/doi.org\/10.1101\/2023.04.12.536572","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41531-023-00574-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,4,12]]},"subtype":"preprint"}}